IL113665A - Amide derivatives their preparation pharmaceutical compositions containing them and their use - Google Patents

Amide derivatives their preparation pharmaceutical compositions containing them and their use

Info

Publication number
IL113665A
IL113665A IL11366595A IL11366595A IL113665A IL 113665 A IL113665 A IL 113665A IL 11366595 A IL11366595 A IL 11366595A IL 11366595 A IL11366595 A IL 11366595A IL 113665 A IL113665 A IL 113665A
Authority
IL
Israel
Prior art keywords
pct
pharmaceutical compositions
compositions containing
amide derivatives
date nov
Prior art date
Application number
IL11366595A
Other languages
English (en)
Other versions
IL113665A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL113665A0 publication Critical patent/IL113665A0/xx
Publication of IL113665A publication Critical patent/IL113665A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/093Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/10Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
    • C07C17/14Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms in the side-chain of aromatic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C07C57/60Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/62Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings and other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/64Acyl halides
    • C07C57/76Acyl halides containing halogen outside the carbonyl halide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/56Unsaturated compounds containing hydroxy or O-metal groups containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62Halogen-containing esters
    • C07C69/65Halogen-containing esters of unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
IL11366595A 1994-05-10 1995-05-09 Amide derivatives their preparation pharmaceutical compositions containing them and their use IL113665A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94303350 1994-05-10

Publications (2)

Publication Number Publication Date
IL113665A0 IL113665A0 (en) 1995-08-31
IL113665A true IL113665A (en) 1999-12-22

Family

ID=8217701

Family Applications (3)

Application Number Title Priority Date Filing Date
IL11366595A IL113665A (en) 1994-05-10 1995-05-09 Amide derivatives their preparation pharmaceutical compositions containing them and their use
IL12496695A IL124966A (en) 1994-05-10 1995-05-09 1-indanyl-and 1-indanylidene-acetic acid derivatives
IL12496698A IL124966A0 (en) 1994-05-10 1998-06-17 1-indanyl- and 1-indanylidene-acetic derivatives

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL12496695A IL124966A (en) 1994-05-10 1995-05-09 1-indanyl-and 1-indanylidene-acetic acid derivatives
IL12496698A IL124966A0 (en) 1994-05-10 1998-06-17 1-indanyl- and 1-indanylidene-acetic derivatives

Country Status (26)

Country Link
US (1) US5708033A (zh)
EP (1) EP0759026B1 (zh)
JP (1) JP3419462B2 (zh)
KR (1) KR100361788B1 (zh)
CN (1) CN1079788C (zh)
AT (1) ATE183496T1 (zh)
AU (1) AU702606B2 (zh)
BR (1) BR9507677A (zh)
CA (1) CA2190009A1 (zh)
DE (1) DE69511544T2 (zh)
DK (1) DK0759026T3 (zh)
ES (1) ES2134472T3 (zh)
FI (1) FI964482A0 (zh)
GR (1) GR3031458T3 (zh)
HK (1) HK1014532A1 (zh)
HU (1) HU219241B (zh)
IL (3) IL113665A (zh)
MX (1) MX9605458A (zh)
MY (1) MY113062A (zh)
NO (1) NO308654B1 (zh)
NZ (1) NZ285134A (zh)
RU (1) RU2145954C1 (zh)
SI (1) SI0759026T1 (zh)
TW (1) TW340109B (zh)
WO (1) WO1995030645A1 (zh)
ZA (1) ZA953753B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391282B1 (en) * 1997-11-10 2002-05-21 Flemington Pharmaceutical Corp. Antihistamine sprays and ointments for relief of delayed contact dermatitis
DE19837069C1 (de) * 1998-08-17 2000-01-05 Bayer Ag Substituierte Zimtsäuren und Zimtsäureester, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von substituierten Indanoncarbonsäureestern
US20040116405A1 (en) * 2001-02-06 2004-06-17 Brian Cox Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity
US6956129B2 (en) * 2001-02-16 2005-10-18 Bayer Aktiengesellschaft Polyhalogen-substituted cinnamic acids and cinnamic acid derivatives and a process for the preparation of polyhalogen-substituted cinnamic acids and cinnamic acid derivatives
ATE327744T1 (de) 2001-03-20 2006-06-15 Sanol Arznei Schwarz Gmbh Neue verwendung von peptidverbindungen bei der behandlung von nicht-neuropathischem entzündungsschmerz
ATE228358T1 (de) 2001-03-21 2002-12-15 Sanol Arznei Schwarz Gmbh Neue verwendung einer klasse von peptidverbindungen zur behandlung von allodynie oder andere arten von chronischen oder phantomschmerzen
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
NZ541008A (en) * 2003-01-13 2007-09-28 Dynogen Pharmaceuticals Inc Method of treating functional bowel disorders
NZ550482A (en) 2004-04-16 2010-08-27 Sanol Arznei Schwarz Gmbh Use of peptidic compounds for the prophylaxis and treatment of chronic headache
BRPI0514721A (pt) 2004-08-27 2008-06-24 Sanol Arznei Schwarz Gmbh uso de compostos de peptìdeos para tratar dor de cáncer ósseo, dor induzida por quimioterapia e nucleosìdeo
NZ567108A (en) * 2005-12-20 2011-10-28 Nps Pharma Inc Fluorinated compounds
KR101518427B1 (ko) 2006-06-15 2015-05-08 유씨비 파르마 게엠베하 상승적 항경련 효과를 갖는 약제학적 조성물
RU2522460C1 (ru) * 2013-01-09 2014-07-10 Федеральное государственное бюджетное учреждение высшего профессионального образования "Кемеровский государственный университет" (КемГУ) Способ получения алкенилантрахинонов

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE371190B (zh) * 1972-03-24 1974-11-11 Kabi Ab
US3325358A (en) * 1962-06-06 1967-06-13 Merck & Co Inc Method of treating inflammation
NO136750C (no) * 1972-06-19 1977-11-02 Takeda Chemical Industries Ltd Fremgangsm}te for fremstilling av indanderivater
JPS5623982B2 (zh) * 1972-12-07 1981-06-03
US5416118A (en) * 1992-04-09 1995-05-16 Schering Corporation Bicyclic amides as inhibitors of acyl-coenzyme A: cholesterol acyl transferase
GB9309621D0 (en) * 1993-05-11 1993-06-23 Wellcome Found Amide derivatives and their therapeutic use

Also Published As

Publication number Publication date
ES2134472T3 (es) 1999-10-01
BR9507677A (pt) 1997-08-19
MY113062A (en) 2001-11-30
WO1995030645A1 (en) 1995-11-16
RU2145954C1 (ru) 2000-02-27
TW340109B (en) 1998-09-11
HUT76465A (en) 1997-09-29
IL124966A (en) 1999-12-22
HU9603103D0 (en) 1997-01-28
SI0759026T1 (en) 1999-10-31
CN1079788C (zh) 2002-02-27
NO964750D0 (no) 1996-11-08
NO308654B1 (no) 2000-10-09
FI964482A (fi) 1996-11-07
NZ285134A (en) 1998-03-25
GR3031458T3 (en) 2000-01-31
DE69511544T2 (de) 1999-12-23
IL113665A0 (en) 1995-08-31
IL124966A0 (en) 1999-01-26
AU2413895A (en) 1995-11-29
EP0759026B1 (en) 1999-08-18
DK0759026T3 (da) 2000-02-28
JP3419462B2 (ja) 2003-06-23
HU219241B (en) 2001-03-28
FI964482A0 (fi) 1996-11-07
DE69511544D1 (de) 1999-09-23
ZA953753B (en) 1996-11-11
KR100361788B1 (ko) 2003-01-24
CA2190009A1 (en) 1995-11-16
HK1014532A1 (en) 1999-09-30
CN1153510A (zh) 1997-07-02
AU702606B2 (en) 1999-02-25
US5708033A (en) 1998-01-13
JPH09512814A (ja) 1997-12-22
ATE183496T1 (de) 1999-09-15
NO964750L (no) 1996-11-08
EP0759026A1 (en) 1997-02-26
MX9605458A (es) 1998-02-28

Similar Documents

Publication Publication Date Title
GB9426103D0 (en) Therapeutic agents
IL108520A0 (en) Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them
IL113665A (en) Amide derivatives their preparation pharmaceutical compositions containing them and their use
IL114241A0 (en) Thiazolidine derivatives their preparation and compositions containing them
IL115184A0 (en) Anthracycline derivatives their preparation and use
HUT76801A (en) 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and medicaments containing them
GR3021314T3 (en) N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders.
PL313037A1 (en) Phenoxphenylocyclopententenylohydroxyureas
TW261605B (zh)
GR3025050T3 (en) Etoposide derivatives, process for their preparation, their use as a drug and in the preparation of a drug for treating cancer.
IL108290A0 (en) Pyrrolidine derivatives, their preparation and medicaments containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees